Hot Investor Mandate: Asia-Based Large Pharma Interested in Global R&D Partnership and Investment Opportunities in Novel Therapeutics & Medical Devices

12 Nov

A listed pharmaceutical company in Asia with 5 Billion of assets under management is actively seeking global R&D partnerships and investment opportunities. Through over 2 decades of arduous efforts, it has become a high-tech pharmaceutical health industry cluster that covers manufacturing, R&D, and sales in the pharmaceutical area.

The firm has focused interest in Traditional Chinese Medicine granules, finished drugs, pharmaceutic adjuvants, active pharmaceutical ingredients, medical devices, medical and health management services. In addition, the firm pays special attention to novel therapeutic innovations in sepsis, anti-infection, and oncology area.

The firm has no specific company or management team requirements.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: